FGF-23 correlates with endocrine and metabolism dysregulation, worse cardiac and renal function, inflammation level, stenosis degree, and independently predicts in-stent restenosis risk in coronary heart disease patients underwent drug-eluting-stent PCI

BACKGROUND: The present study aimed to assess the correlation of fibroblast growth factor (FGF)-23 expression with clinical characteristics, then further explore its value in predicting 2-year in-stent restenosis (ISR) risk in coronary heart disease (CHD) patients underwent percutaneous coronary int...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Tingting, Fu, Yang, Wang, Yanbo, Li, Wei, Zhao, Jiayu, Wang, Xun, Wang, Haiyan, Zhao, Ying, Fu, Xianghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791850/
https://www.ncbi.nlm.nih.gov/pubmed/33413149
http://dx.doi.org/10.1186/s12872-020-01839-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791850/
https://www.ncbi.nlm.nih.gov/pubmed/33413149
http://dx.doi.org/10.1186/s12872-020-01839-w

Ejemplares similares